Table 2 Characteristics of HD patients who died or survived any time after COVID-19 presentation
Latin America | North America | |||
|---|---|---|---|---|
Mean ± SD or N (%) | Mean ± SD or N (%) | |||
Parameter | Died anytime | Survived | Died anytime | Survived |
Demographics | ||||
Age (years) | 66 ± 11.5 | 57.5 ± 15.3 | 68.94 ± 12.44 | 61.96 ± 13.91 |
Male | 644 (63.6) | 1495 (60.1) | 2510 (56.7) | 9343 (54.3) |
BMI (Kg/m^2) | 26.5 ± 5.9 | 26.2 ± 5.9 | 29.1 ± 8.8 | 30.1 ± 8.8 |
Vintage (years) | 5.23 ± 4.9 | 5.18 ± 4.8 | 4.54 ± 4.07 | 3.93 ± 4.07 |
Catheter exposure | ||||
> 90 days | 264 (26.3) | 430 (17.5) | 999 (22.6) | 3592 (20.9) |
> 120 days | 208 (20.7) | 326 (13.3) | 983 (22.2) | 3538 (20.6) |
> 180 days | 199 (19.8) | 301 (12.2) | 949 (21.4) | 3452 (20.1) |
Cause of kidney failure | ||||
Diabetic nephropathy | 263 (26.4) | 481 (19.6) | 2432 (54.9) | 9295 (54.0) |
Hypertensive nephrosclerosis | 114 (11.4) | 270 (11) | 1076 (24.3) | 4835 (28.1) |
Other | 619 (62.1) | 1705 (69.4) | 915 (20.7) | 3043 (17.7) |
Comorbidities | ||||
Diabetes | 366 (37.9) | 645 (27.2) | 3454 (78.0) | 12,471 (72.5) |
Hypertension | 376 (39) | 1032 (43.5) | 3074 (69.5) | 11,518 (67.0) |
Heart failure | 8 (0.8) | 11 (0.4) | 1093 (24.7) | 3201 (18.6) |
Ischemic heart disease | 5 (0.5) | 24 (1.0) | 1098 (24.8) | 3174 (18.5) |
Cancer | 9 (0.9) | 22 (0.9) | 250 (5.6) | 610 (3.5) |
COPD | 4 (0.4) | 14 (0.6) | 515 (11.6) | 1504 (8.7) |
Liver disease | 4 (0.4) | 17 (0.7) | 530 (12.0) | 1770 (10.3) |
Country | ||||
Argentina | 382 | 1021 | ||
Colombia | 340 | 822 | ||
Ecuador | 279 | 629 | ||
United States | 4426 | 17,198 | ||